(Total Views: 622)
Posted On: 05/22/2020 6:00:35 PM
Post# of 9129
Re: nmbr1stckpckr #6257
Hmm....It looks like BioMotiv's focus is on new drug development. Not sure if they'd be interested in diagnostic tool, but the point of my previous point is still valid. Dr. Rogers has many connections for precisely what Nanologix needs to get its tech to market!
(0)
(0)
Scroll down for more posts ▼